» Articles » PMID: 11696277

Alcoholic Hepatitis

Overview
Specialty Gastroenterology
Date 2001 Nov 7
PMID 11696277
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Alcoholic hepatitis is a multisystem disease seen in individuals who chronically abuse alcohol. When severe, it is associated with a very high mortality rate, with nearly 50% of severely affected persons dying within 1 month of hospitalization. Primary therapy is complete alcohol abstinence and supportive care. Corticosteroids have been shown to be beneficial in a subset of severely ill patients with alcoholic hepatitis and concomitant hepatic encephalopathy. Pentoxifylline has been shown to improve short-term survival rates. Other pharmacologic interventions, including colchicine, propylthiouracil, calcium channel antagonists, and insulin with glucagon infusions, have not been proven to be beneficial. Nutritional supplementation with high-calorie, high-protein diets does not improve mortality rates. Orthotopic liver transplantation is highly controversial in this population of patients and currently is not indicated as definitive treatment. Extracorporeal liver support devices are still in their developmental stage and are only experimental.

Citing Articles

A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis.

Antar R, Wong P, Ghali P Can J Gastroenterol. 2012; 26(7):463-7.

PMID: 22803023 PMC: 3395449. DOI: 10.1155/2012/945707.


Alcoholic Hepatitis.

Crosse K, Anania F Curr Treat Options Gastroenterol. 2002; 5(6):417-423.

PMID: 12408778 DOI: 10.1007/s11938-002-0029-7.

References
1.
Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O . Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000; 119(6):1637-48. DOI: 10.1053/gast.2000.20189. View

2.
Feher J, Cornides A, Romany A, Karteszi M, Szalay L, Gogl A . A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis. J Hepatol. 1987; 5(2):224-31. DOI: 10.1016/s0168-8278(87)80577-9. View

3.
Mendenhall C, Anderson S, Goldberg S, Kiernan T, Seeff L, Sorrell M . Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 1984; 311(23):1464-70. DOI: 10.1056/NEJM198412063112302. View

4.
Depew W, Boyer T, Omata M, Redeker A, Reynolds T . Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology. 1980; 78(3):524-9. View

5.
Ramond M, Poynard T, RUEFF B, Mathurin P, Theodore C, Chaput J . A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 1992; 326(8):507-12. DOI: 10.1056/NEJM199202203260802. View